184 related articles for article (PubMed ID: 25724350)
1. Impact of interfractional changes in head and neck cancer patients on the delivered dose in intensity modulated radiotherapy with protons and photons.
Müller BS; Duma MN; Kampfer S; Nill S; Oelfke U; Geinitz H; Wilkens JJ
Phys Med; 2015 May; 31(3):266-72. PubMed ID: 25724350
[TBL] [Abstract][Full Text] [Related]
2. Potential proton and photon dose degradation in advanced head and neck cancer patients by intratherapy changes.
Stützer K; Jakobi A; Bandurska-Luque A; Barczyk S; Arnsmeyer C; Löck S; Richter C
J Appl Clin Med Phys; 2017 Nov; 18(6):104-113. PubMed ID: 28921843
[TBL] [Abstract][Full Text] [Related]
3. Intensity modulated photon and proton therapy for the treatment of head and neck tumors.
Steneker M; Lomax A; Schneider U
Radiother Oncol; 2006 Aug; 80(2):263-7. PubMed ID: 16916557
[TBL] [Abstract][Full Text] [Related]
4. NTCP reduction for advanced head and neck cancer patients using proton therapy for complete or sequential boost treatment versus photon therapy.
Jakobi A; Stützer K; Bandurska-Luque A; Löck S; Haase R; Wack LJ; Mönnich D; Thorwarth D; Perez D; Lühr A; Zips D; Krause M; Baumann M; Perrin R; Richter C
Acta Oncol; 2015; 54(9):1658-64. PubMed ID: 26340301
[TBL] [Abstract][Full Text] [Related]
5. Dose painting with IMPT, helical tomotherapy and IMXT: a dosimetric comparison.
Thorwarth D; Soukup M; Alber M
Radiother Oncol; 2008 Jan; 86(1):30-4. PubMed ID: 18061294
[TBL] [Abstract][Full Text] [Related]
6. Multi-scenario based robust intensity-modulated proton therapy (IMPT) plans can account for set-up errors more effectively in terms of normal tissue sparing than planning target volume (PTV) based intensity-modulated photon plans in the head and neck region.
Stuschke M; Kaiser A; Abu Jawad J; Pöttgen C; Levegrün S; Farr J
Radiat Oncol; 2013 Jun; 8():145. PubMed ID: 23773560
[TBL] [Abstract][Full Text] [Related]
7. Impact of grid size on uniform scanning and IMPT plans in XiO treatment planning system for brain cancer.
Rana S; Zheng Y
J Appl Clin Med Phys; 2015 Sep; 16(5):447–456. PubMed ID: 26699310
[TBL] [Abstract][Full Text] [Related]
8. Dosimetric Evaluation of Incorporating Patient Geometric Variations Into Adaptive Plan Optimization Through Probabilistic Treatment Planning in Head and Neck Cancers.
Liu Q; Liang J; Zhou D; Krauss DJ; Chen PY; Yan D
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):985-997. PubMed ID: 29976511
[TBL] [Abstract][Full Text] [Related]
9. Validation of Fully Automated Robust Multicriterial Treatment Planning for Head and Neck Cancer IMPT.
Huiskes M; Kong W; Oud M; Crama K; Rasch C; Breedveld S; Heijmen B; Astreinidou E
Int J Radiat Oncol Biol Phys; 2024 Jul; 119(3):968-977. PubMed ID: 38284961
[TBL] [Abstract][Full Text] [Related]
10. Improve the dosimetric outcome in bilateral head and neck cancer (HNC) treatment using spot-scanning proton arc (SPArc) therapy: a feasibility study.
Liu G; Li X; Qin A; Zheng W; Yan D; Zhang S; Stevens C; Kabolizadeh P; Ding X
Radiat Oncol; 2020 Jan; 15(1):21. PubMed ID: 32000817
[TBL] [Abstract][Full Text] [Related]
11. ART for head and neck patients: On the difference between VMAT and IMPT.
Góra J; Kuess P; Stock M; Andrzejewski P; Knäusl B; Paskeviciute B; Altorjai G; Georg D
Acta Oncol; 2015; 54(8):1166-74. PubMed ID: 25850583
[TBL] [Abstract][Full Text] [Related]
12. PTV-based IMPT optimization incorporating planning risk volumes vs robust optimization.
Liu W; Frank SJ; Li X; Li Y; Zhu RX; Mohan R
Med Phys; 2013 Feb; 40(2):021709. PubMed ID: 23387732
[TBL] [Abstract][Full Text] [Related]
13. Assessment of improved organ at risk sparing for meningioma: light ion beam therapy as boost versus sole treatment option.
Mock U; Georg D; Sölkner L; Suppan C; Vatnitsky SM; Flechl B; Mayer R; Dieckmann K; Knäusl B
Radiother Oncol; 2014 Jun; 111(3):451-6. PubMed ID: 25012644
[TBL] [Abstract][Full Text] [Related]
14. Proton versus photon deep inspiration breath hold technique in patients with hodgkin lymphoma and mediastinal radiation : A PLANNING COMPARISON OF DEEP INSPIRATION BREATH HOLD INTENSITY MODULATION RADIOTHERAPY AND INTENSITY MODULATED PROTON THERAPY.
Baues C; Marnitz S; Engert A; Baus W; Jablonska K; Fogliata A; Vásquez-Torres A; Scorsetti M; Cozzi L
Radiat Oncol; 2018 Jul; 13(1):122. PubMed ID: 29970105
[TBL] [Abstract][Full Text] [Related]
15. Comparison of linear and nonlinear programming approaches for "worst case dose" and "minmax" robust optimization of intensity-modulated proton therapy dose distributions.
Zaghian M; Cao W; Liu W; Kardar L; Randeniya S; Mohan R; Lim G
J Appl Clin Med Phys; 2017 Mar; 18(2):15-25. PubMed ID: 28300378
[TBL] [Abstract][Full Text] [Related]
16. Feasibility of automated proton therapy plan adaptation for head and neck tumors using cone beam CT images.
Kurz C; Nijhuis R; Reiner M; Ganswindt U; Thieke C; Belka C; Parodi K; Landry G
Radiat Oncol; 2016 Apr; 11():64. PubMed ID: 27129305
[TBL] [Abstract][Full Text] [Related]
17. Potential skin morbidity reduction with intensity-modulated proton therapy for breast cancer with nodal involvement.
Fellin F; Iacco M; D'Avino V; Tommasino F; Farace P; Palma G; Conson M; Giacomelli I; Zucchetti C; Falcinelli L; Amichetti M; Aristei C; Cella L
Acta Oncol; 2019 Jun; 58(6):934-942. PubMed ID: 30938217
[No Abstract] [Full Text] [Related]
18. The energy margin strategy for reducing dose variation due to setup uncertainty in intensity modulated proton therapy (IMPT) delivered with distal edge tracking (DET).
Zhang M; Flynn RT; Mo X; Mackie TR
J Appl Clin Med Phys; 2012 Sep; 13(5):3863. PubMed ID: 22955652
[TBL] [Abstract][Full Text] [Related]
19. PTV-based VMAT vs. robust IMPT for head-and-neck cancer: A probabilistic uncertainty analysis of clinical plan evaluation with the Dutch model-based selection.
Rojo-Santiago J; Korevaar E; Perkó Z; Both S; Habraken SJM; Hoogeman MS
Radiother Oncol; 2023 Sep; 186():109729. PubMed ID: 37301261
[TBL] [Abstract][Full Text] [Related]
20. Proton beam radiotherapy versus fractionated stereotactic radiotherapy for uveal melanomas: A comparative study.
Weber DC; Bogner J; Verwey J; Georg D; Dieckmann K; Escudé L; Caro M; Pötter R; Goitein G; Lomax AJ; Miralbell R
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):373-84. PubMed ID: 16168832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
